Meet the Proteona team at the 11th AFOB Regional Symposium (ARS) conference in Singapore
Innovative genomic and proteomic analysis platform for Immuno-Oncology and Single Cell BioMedical Applications
SINGAPORE, 22 January 2019 - Proteona announced that Dr Jonathan Scolnick, Chief Scientific Officer, will present at Asian Federation of Biotechnology (AFOB) Regional Symposium (ARS) conference in Singapore on the 24th January, 2019.
Dr Scolnick will share on Proteona's recent development on combining protein and gene expression to investigate the manufacturing of cell therapies.
For media queries, please contact:
Dr Andreas Schmidt
Proteona Pte. Ltd. is a new biomedical company based in Singapore and San Diego that is pioneering the use of DNA barcoded antibodies to provide both proteomic and genomic information from the same single cells. Proteona is a spin-off from the National University of Singapore (NUS) and the Agency for Science, Technology and Research’s (A*STAR). The platform is a comprehensive sample to answer service that enables users to phenotype cells using standard protein markers and gain a deeper understanding of cell activity based upon their gene expression profiles.